Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2009, Vol. 113, No. 3, pp. 594-603.
Prepublished online as a Blood First Edition Paper on October 7, 2008; DOI 10.1182/blood-2008-04-150987.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2008-04-150987v1
113/3/594    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parikh, K.
Right arrow Articles by Visser, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parikh, K.
Right arrow Articles by Visser, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 10, 2008
Accepted September 16, 2008

Extracellular ligation-dependent CD45RB enzymatic activity negatively regulates lipid raft signal transduction

Kaushal Parikh*, Sibrand Poppema, Maikel P Peppelenbosch, and Lydia Visser

Department of Cell Biology, University Medical Center Groningen, Groningen, Netherlands
Department of Pathology, University Medical Center Groningen, Groningen, Netherlands

* Corresponding author; email: k.parikh{at}med.umcg.nl.

CD45 is the most prominent membrane protein on lymphocytes. The function and regulation of this protein tyrosine phosphatase (PTP) remains largely obscure, mainly because of the lack of a known ligand and it still remains unknown whether such tyrosine phosphatases are subject to extracellular control at all. We report that an anti-CD45RB antibody that prevents rejection and induces tolerance, activates CD45RB tyrosine phosphatase enzymatic activity in T lymphocytes allowing us to directly monitor the effects of increased CD45RB activity on signal transduction. By employing both kinase substrate peptide arrays as well as conventional biochemistry, we also provide evidence of the various kinases involved in bringing about the inhibitory effect of this antibody on CD3 induced TCR signaling. Furthermore, we report that activated CD45RB translocates to lipid rafts and interferes with lipid raft localisation and activation state of CD45 substrate Lck. Thus, these findings indeed prove that CD45 is subject to extracellular control and also define a novel mechanism by which receptor tyrosine phosphatases control lymphocyte biology and provide further insight into the intracellular signaling pathways effected by anti-CD45RB mAb treatment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020